secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLARGO, INC. (BLGO)
CIK:        0000880242
Form:       8-K
Filed at:   2025-03-31T23:59:59+00:00
Accession:  0001437749-25-010296
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioLargo reports record 2024 revenues of $17.8M, up 45% YoY; net loss narrows 6%
--------------------------------------------------------------------------------

- Revenue $17.779M, up 45% from 2023; tenth consecutive year of revenue growth.
- Net loss $4.347M, down 6% YoY; $3.490M of loss from Clyra Medical operations.
- Issued 42% fewer shares in 2024 vs 2023; cash and equivalents $3.548M at Dec 31.
- Clyra surgical irrigation products progressing toward national rollout with distribution partner.
- Non-cash expenses (stock/options) $2.479M, representing 57% of net loss.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/880242/000143774925010296/0001437749-25-010296-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/880242/000143774925010296/blgo20250331_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-010296

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer